Funding Eligibility
Medical Treatment Facility Role 2 Forward–Capability Development (MTF R2F–CD)
What does Medical Treatment Facility Role 2 Forward–Capability Development (MTF R2F–CD) reveal about European defence funding, eligibility and procurement?
The MTF R2F–CD project, included in the sixth wave of the Permanent Structured Cooperation (PESCO) launched in May 2025.
Full figures, sources and the complete assessment are in the report — Read the full DFM Analysis →
Platform publication · DFM Analysis report · 2026-06-13
The MTF R2F–CD project, included in the sixth wave of the Permanent Structured Cooperation (PESCO) launched in May 2025, aims to enhance the EU’s forward medical support capabilities. The initiative focuses on the development of rapidly deployable Role 2 medical treatment facilities, specifically designed to provide advanced trauma care and damage-control surgery in proximity to operational theatres.
Continue with the full evidence
This public thread is the short analytical version. The full DFM Analysis report adds the underlying figures and data, the complete source base, and the full procurement & capital-market assessment behind this summary.
Annual Professional unlocks the complete archive and DFM Intelligence (2,200+ company profiles) — See plans →
Original DFM analysis
Medical Treatment Facility Role 2 Forward–Capability Development (MTF R2F–CD)
FAQ
What is Medical Treatment Facility Role 2 Forward–Capability Development (MTF R2F–CD)?
The MTF R2F–CD project, included in the sixth wave of the Permanent Structured Cooperation (PESCO) launched in May 2025, aims to enhance the EU’s forward medical support capabilities.
Related DFM Platform threads
- Autonomous Swarm Infrastructure: Edge AI & Middleware Solutions Funding Eligibility
- Isar Aerospace and European Launch Autonomy Funding Eligibility
- Alternative PNT and GNSS-Denied Navigation Funding Eligibility
- Strategic Enablers in the 2026 European Defence Fund: Energy, Materials and Eligibility Funding Eligibility
- Tenzir — Sovereign Security Data Pipelines for European Strategic Autonomy Funding Eligibility
- LSMedical OÜ – Strategic-Technological Analysis Funding Eligibility
Explore this category Funding & Eligibility
Professional requests (internal interest signal — not a marketplace; nothing is charged or promised)
See Professional & Institutional Access — plans, group/institutional seats and contact →
Defence Finance Monitor is an analytical and informational product. It does not constitute investment advice, financial advice or a recommendation to buy or sell securities. Payment and subscription happen on DFM Analysis — the platform never processes payment.
Professional comments
Join the discussion on DFM Analysis.
Read & subscribe on DFM Analysis →